Work

An Immunostimulatory Glycolipid That Blocks SARS-CoV-2, RSV, and Influenza Infections In Vivo

Year: 2023

Type: preprint

Source: Research Square

DOI: 10.21203/rs.3.rs-1785892/v2

Authors: David Ho, Moriya Tsuji, Manoj Nair, Kazuya Masuda, Candace Castagna, Zhenlu Chong, Tamarand Darling, Kuljeet Seehra, Ágata Ribeiro, Geovane Ferreira, Laura Corredor, Jordana Alves Coelho-dos-Reis, Yukiko Tsuji, Adrianus Boon, Michael Diamond, Yaoxing Huang, Youngmin Hwang, Munemasa Mori

Institutions: Columbia University Irving Medical Center, Columbia University, Aaron Diamond AIDS Research Center, Washington University in St. Louis, Fiocruz Minas, Fundação Oswaldo Cruz, Universidade Federal de Minas Gerais

Language: English

Topic: SARS-CoV-2 and COVID-19 Research

Subfield: Infectious Diseases

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W4323537909

Cites: 27

Cited by:

Related to: 10